Survival after primary enucleation for choroidal melanoma: Changes induced by the introduction of conservative therapies

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 5, 2007, Pages 657-663

  Gambrelle, J ^a   Grange, J D ^a   Devouassoux Shisheboran, M ^a   Rivoire, M ^c   Baggetto, L G ^b   Jean Louis, B ^a   Fleury, J ^a   Kodjikian, Laurent ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

Primary enucleation; Prognostic factors; Survival; Uveal melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CHOROID MELANOMA; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; ENUCLEATION; EPITHELIOID CELL; FEMALE; FRANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; MALE; MULTIVARIATE ANALYSIS; PATIENT COUNSELING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTON THERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; UVEA MELANOMA; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; AGED, 80 AND OVER; CHOROID NEOPLASMS; EYE ENUCLEATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34250775635     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0477-1     Document Type: Article

References (31)

1. Baggetto L, Gambrelle J, Dayan G, Labialle S, Barakat S, Michaud M, Grange J, Gayet L (2005) Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: Current views and new therapeutic prospects. Cancer Treat Rev 31:361-379
2. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS (1995) Treatment of uveal melanoma metastatic to the liver: A review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 76:1665-1670
3. Callender G (1931) Malignant melanotic tumors of the eye: A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 36:131-141
4. Coleman K, Baak JP, Van Diest P, Mullaney J, Farrell M, Fenton M (1993) Prognostic factors following enucleation of 111 uveal melanomas. Br J Ophthalmol 77:688-692
5. (COMS) COMS (1998) The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: Characteristics of patients enrolled and not enrolled. COMS report N°9. Am J Ophthalmol 125:767-778
6. Courdi A, Caujolle JP, Grange JD, Diallo-Rosier L, Sahel J, Bacin F, Zur C, Gastaud P, Iborra-Brassart N, Herault J, Chauvel P (1999) Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 45:5-11
7. Cox D (1972) Regression models and life-tables (with discussions). J Roy Statis Soc Series B 34:187-220
8. Davies W (1963) Malignant melanomas of the choroid and ciliary body. A clinicopathologic study. Am J Ophthalmol 55:541-546
9. De Potter P, Shields CL, Shields JA (1996) New treatment modalities for uveal melanoma. Curr Opin Ophthalmol 7:27-32
10. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T (2000) Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment. Ophthalmology 107:1443-1449
11. Gambrelle J, Kodjikian L, Grange JD (2005) Survival after primary enucleation of largest uveal melanomas. Acta Ophthalmol Scand 83:398-399
12. Gragoudas E, Goitein G, Koehler A, Constable IJ, Wagner M, Verhey L, Tepper J, Suit H, Brockhurst R, Schneider R, Johnson K (1978) Proton irradiation of choroidal melanomas: Preliminary results. Arch Ophthalmol 96:1583-1591
13. Grange JD, Ducourneau D, Taillanter-Francoz N, Patricot L, Gérard JP (1981) Technic for enucleation if a closed chamber for malignant melanoma of the choroid [Translation]. Bull Soc Ophtalmol Fr 81:679-681
14. Grange JD, Gerard JP, Ragab M, Quintero P, Delaroche G, Jean-Louis B, Sentenac I, Fontaniere B, Bievelez B (1989) Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106) (Translation). Bull Soc Ophtalmol Fr 89:679-682
15. Isager P, Ehlers N, Overgaard J (2004) Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand 82:517-525
16. Isager P, Ehlers N, Overgaard J (2005) Survival after enucleation and radiation brachytherapy for choroidal and ciliary body melanomas. Acta Ophthalmol Scand 83:398-399
17. Jensen O (1963) Malignant melanomas of the uvea in Denmark 1943-1952. A clinical, histopathological, and prognostic study. Acta Ophthalmol 75:1-220
18. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481
19. Kodjikian L, Grange JD, Baldo S, Baillif S, Garweg J, Rivoire M (2005) Prognostic factors of liver metastases from uveal melanoma. Graefes Arch Clin Exp Ophthalmol 243:985-993
20. Kodjikian L, Roy P, Rouberol F, Garweg J, Chauvel P, Manon L, Jean-Louis B, Little R, Sasco A, Grange JD (2004) Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol 137:1002-1010
21. Lommatzsch P, Dietrich B (1976) Survival rate of patient with choroidal melanoma. Ophthalmologica 173:453-462
22. Lommatzsch PK, Werschnik C, Schuster E (2000) Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 238:129-137
23. McLean I, Foster W, Zimmerman L (1983) Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 96:502-509
24. Paul E, Parnell B, Fraker M (1962) Prognosis of malignant melanomas of choroid and ciliary body. Int Ophthalmol Clin 2:388-402
25. Raivio I (1977) Uveal melanoma in Finland. Acta Ophthalmol 133:1-64
26. Rouberol F, Roy P, Kodjikian L, Gérard J, Jean-Louis B, Grange JD (2004) Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol 137:893-900
27. Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, Freire J (2002) Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. Ophthalmology 109:1838-1849
28. Shields J, Shields C (1992) Intraocular tumors: A text and atlas. WB Saunders, Philadelphia
29. Singh AD, Topham A (2003) Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 110:962-965
30. Sobin L, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley-Lissinc, Genève
31. Zografos L, Uffer S (2002) Prognosis following enucleation (Translation). In: Zografos L (ed) Intraocular tumors (Translation). (Rapport de la société Française d'Ophtalmologie). Masson, Paris, pp 229-242